AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

AASLD’s new practice guidance on the clinical management of NAFLD recommends sequentially integrating cT1 with other noninvasive tests for the identification and risk-stratification of patients with “at-risk” NASH in secondary/speciality care to facilitate better clinical management of these patients.